Recent Updates
Recently added Catalysts
NVAX Positive Sentiment Score: 75/100

Novavax to Participate in Upcoming September Conferences

Friday, September 8, 2023 1 min read
Key Takeaway: Novavax, Inc. announced its participation in two investor conferences scheduled for September 11 and 12, 2023. The company's executives, including Jim Kelly and Robert Walker, will engage in fireside chats at both events, providing an opportunity to discuss their innovative vaccine development initiatives. These conferences may enhance the company's visibility in the investment community and highlight its efforts in addressing infectious diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in two major investor conferences can boost visibility.
  • Showcases leadership engagement from key executives Jim Kelly and Robert Walker.
  • Focus on innovative vaccine development aligns with current health priorities.

Full Press Release Details

GAITHERSBURG, Md., Sept. 8, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in two upcoming investor conferences.
H.C. Wainwright 25 th Annual Global Investment Conference:
Fireside Chat
Date: Monday, September 11, 2023
Time: 4:30 – 5:00 p.m. Eastern Daylight Time (EDT)
Location: Lotte New York Palace Hotel
Moderator: Vernon Bernardino, Managing Director, Senior Healthcare Analyst
Novavax participants: Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer and Robert Walker, Senior Vice President, Chief Medical Officer
Conference
Event: Investor Meetings
Date: Monday, September 11, 2023
Baird 2023 Global Healthcare Conference:
Fireside Chat
Date: Tuesday, September 12, 2023
Time: 10:15 – 10:45 a.m. EDT
Location: Intercontinental New York Barclay Hotel
Moderator: Joel L. Beatty, MD, CFA, Senior Research Analyst – Biotechnology
Novavax participants: Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer and Robert Walker, Senior Vice President, Chief Medical Officer
Conference
Event: Investor Meetings
Date: Tuesday, September 12, 2023
A replay of the recorded fireside sessions will be available through the Events and Presentations page of the Company's website at ir.novavax.com for 90 days from the date of the conference.
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID, influenza and COVID and influenza combined. Please visit novavax.com and LinkedIn for more information.
SOURCE Novavax, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Novavax participate in the H.C. Wainwright conference?

Novavax will participate on September 11, 2023, from 4:30 to 5:00 p.m. EDT.

Who are the Novavax participants at the investor conferences?

Jim Kelly and Robert Walker will represent Novavax at the conferences.

Is there a replay available for the fireside chats?

Yes, a replay will be available for 90 days on their Events and Presentations page.

What type of vaccines does Novavax develop?

Novavax focuses on vaccines for serious infectious diseases, including COVID and influenza.

Where is Novavax headquartered?

Novavax is based in Gaithersburg, Maryland, USA.

Tags: NVAX Viatris Investor Conferences Healthcare Novavax investor conferences biotech investment vaccine development
Last updated: Sep 8, 2023